Courtney Bailey
Gynecologic Oncology · Charleston, SCNPI 1992116834
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 75.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $3,386 and has fallen 88.6% since, to $385 in 2025.
Across 51 payments — averaging $95.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Merck$364
- Eisai Inc.$168
- GSK$142
- AstraZeneca$108
- Genmab U.S., Inc.$68
- plus $351 from 8 others
What the payments were for
- Travel & lodging$2,32848%
- Food & beverage$1,45730%
- Education$1,07522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $3,660 |
| Merck | 11 | $364 |
| Eisai Inc. | 7 | $168 |
| GSK | 2 | $142 |
| AstraZeneca | 4 | $108 |
| Genmab U.S., Inc. | 3 | $68 |
| AbbVie | 2 | $66 |
| Medtronic | 2 | $64 |
| Myriad Genetic Laboratories, Inc. | 4 | $59 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| Johnson & Johnson | 1 | $25 |
| Novartis | 1 | $23 |
| Axonics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,606
- DAVINCI XI$1,000
- ZEJULA$125
- KEYTRUDA$118
How this compares
Too few gynecologic oncology providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $18,965 |
| Megestrol Acetate | 25 | $2,724 |
| Estradiol | 42 | $2,467 |
| Medroxyprogesterone Acetate | 39 | $1,339 |
| Ondansetron Hcl | 62 | $633 |
| Prochlorperazine Maleate | 27 | $391 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $274 |
| Letrozole | 30 | $245 |
| Potassium Chloride | 26 | $238 |
| Oxycodone Hcl | 34 | $221 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 19 | $203 |
| Dexamethasone | 46 | $171 |
| Olanzapine | 18 | $97 |
| Gabapentin | 11 | $97 |
| Tramadol Hcl | 31 | $80 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Charleston
- Whitney GraybillCharleston$81K
- Jonathan FooteCharleston$3K
- Catherine WatsonCharleston$3K
- Brian OrrCharleston$3K
- Ward KatsanisCharleston$1K
- Thomas JenningsCharleston$1K
- David MysonaCharleston$73
- William MerrittColumbia$9K
- Mark MillerWest Columbia$8K
- James WilliamsColumbia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.